Latest filing published 01 Feb 2022 for Bolt Biotherapeutics, Inc., €13k.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Edith A. Perez: trading record in brief
This profile gathers the share dealings of Edith A. Perez in Bolt Biotherapeutics, Inc., where the filings describe the role as senior executive. Between 4 June 2021 and 22 December 2021, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €14k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 option exercise. Since January 2022: 2 purchases and no sales on the market.
Most recently, on 1 February 2022, the filings show an open-market purchase worth €1,687 in Bolt Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 57 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Edith A. Perez
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 917 shares@ US$16.65100.0% of flowCommon StockSEC:0000899243-22-003917:0Canonical exit: 2 Sept 2021 (T+90)
1 of 1 declaration